Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Kyowa Hakko Kirin Co Ltd    4151   JP3256000005

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on KYOWA HAKKO KIRIN CO LTD
08/09 Kyowa Hakko Kirin Announced Kyowa Medex Acquired approval for Insurance Cover..
08/08 KYOWA HAKKO KIRIN : Announced Kyowa Medex Acquired approval for Insurance Covera..
07/21 KYOWA HAKKO KIRIN : Patent Issued for Pharmaceutical Composition Comprising Anti..
07/07 KYOWA HAKKO KIRIN : Researchers at Kyowa Hakko Kirin Co. Ltd. Release New Data o..
07/04 KYOWA HAKKO KIRIN : LUMICEF® approved in Japan(112KB)
06/29 Ultragenyx Receives Breakthrough Therapy Designation for KRN23 in Pediatric P..
06/29 KYOWA HAKKO KIRIN : US Food and Drug Administration Granted Breakthrough Therapy..
06/28 KYOWA HAKKO KIRIN : US Food and Drug Administration Granted Breakthrough Therapy..
06/28 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
06/23 KYOWA HAKKO KIRIN : Studies from Kyowa Hakko Kirin Co. Ltd. Describe New Finding..
06/09 KYOWA HAKKO KIRIN : Researchers from Kyowa Hakko Kirin Co. Ltd. Provide Details ..
06/07 Medgenics Enters into Agreement with Kyowa Hakko Kirin
06/06 KYOWA HAKKO KIRIN : Announces Preliminary Results from Pivotal Phase 2 Study of ..
06/06 GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson %..
06/06 KYOWA HAKKO KIRIN : Announces Preliminary Results from Pivotal Phase 2 Study of ..
06/02 KYOWA HAKKO KIRIN : Studies from Kyowa Hakko Kirin Co. Ltd. Add New Findings in ..
05/24 KYOWA HAKKO KIRIN : Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal ..
05/23 KYOWA HAKKO KIRIN : Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal ..
05/17 Positive benralizumab results in severe asthma
04/19 KYOWA HAKKO KIRIN : Borders-based pharma firm in Japanese-led rebrand
04/19 KYOWA HAKKO KIRIN : ProStrakan rebrands as Kyowa Kirin International PLC
04/19 KYOWA HAKKO KIRIN : Medicine firm aims to unify its image with a rebrand
04/18 KYOWA HAKKO KIRIN : ProStrakan rebrands as Kyowa Kirin
04/04 KYOWA HAKKO KIRIN : BioWa Announces Office Relocation to Princeton, NJ and appoi..
04/01 KYOWA HAKKO KIRIN : Matters concerning controlling shareholders
04/01 KYOWA HAKKO KIRIN : BioWa Announces Office Relocation to Princeton, NJ and appoi..
03/31 KYOWA HAKKO KIRIN : Matters concerning controlling shareholders(44KB)
03/24 KYOWA HAKKO KIRIN : Notice regarding allotment of stock acquisition rights (stoc..
03/15 AVEO Oncology Reports Full Year 2015 Financial Results and Provides Business ..
03/02 ProStrakan acquires rights for drug easing side effect of pain pills
03/02 KYOWA HAKKO KIRIN : Initiation of Operations for Drug Product Manufacturing Faci..
03/01 AstraZeneca enters into agreement with ProStrakan for rights to Moventig in E..
03/01 KYOWA HAKKO KIRIN : AstraZeneca sells drug for $70 million as divestment drive c..
02/29 KYOWA HAKKO KIRIN : Entries Now Publicly Available from the 'Commitment to Life'..
02/26 KYOWA HAKKO KIRIN : Change of Representative Directors at Kyowa Medex(31KB)
02/19 KYOWA HAKKO KIRIN : Notice regarding stock acquisition rights for the purpose of..
02/11 KYOWA HAKKO KIRIN : Patent Issued for Therapeutic Agent for Mood Disorders (USPT..
02/04 KYOWA HAKKO KIRIN : Data on Immunoglobulins Reported by Researchers at Kyowa Hak..
02/04 KYOWA HAKKO KIRIN : Study Results from Kyowa Hakko Kirin Co. Ltd. Broaden Unders..
02/01 KYOWA HAKKO KIRIN : Change in the Company Name of Western Pharmaceutical Subsidi..
01/29 KYOWA HAKKO KIRIN : Announces FY2016-2020 Mid-term Business Plan(123KB)
01/29 KYOWA HAKKO KIRIN : Appendix to the Consolidated Financial Summary Fiscal 2015(1..
01/29 KYOWA HAKKO KIRIN : Consolidated Financial Summary Fiscal 2015(221KB)
01/29 KYOWA HAKKO KIRIN : Results Presentation Fiscal 2015(1,924KB)
01/29 KYOWA HAKKO KIRIN : Change in the Company Name of Western Pharmaceutical Subsidi..
01/26 Kyowa Hakko Kirin Entered an Agreement with Sandoz for Exclusive Marketing Ri..
01/14 KYOWA HAKKO KIRIN : Reports from Kyowa Hakko Kirin Co. Ltd. Provide New Insights..
01/11 KYOWA HAKKO KIRIN : BioWa opens POTELLIGENT® Technology license to customers for..
01/07 KYOWA HAKKO KIRIN : Investigators from Kyowa Hakko Kirin Co. Ltd. Release New Da..
2015 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for final dividend
2015 KYOWA HAKKO KIRIN : Launch of the Web Comic "The Story of Basic Immunology"
2015 Kyowa Medex Launched 'Liaison 25 -hydroxyvitamin D Total' in Japan
2015 KYOWA HAKKO KIRIN : Medex Launched "Liaison 25 -hydroxyvitamin D Total" in Japan
2015 Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 ..
2015 KYOWA HAKKO KIRIN : New Findings from Kyowa Hakko Kirin Co. Ltd. in Apoptosis Pr..
2015 Japan stocks lower at close of trade; Nikkei 225 down 0.37%
2015 KYOWA HAKKO KIRIN : Announces Commencement of Phase 3 Clinical Study of KHK7580 ..
2015 KYOWA HAKKO KIRIN : New Hot Flashes Findings from Kyowa Hakko Kirin Co. Ltd. Dis..
2015 KYOWA HAKKO KIRIN : Studies Conducted at Kyowa Hakko Kirin Co. Ltd. on Myeloid L..
2015 KYOWA HAKKO KIRIN : New Findings in Chronic Kidney Disease Described from Kyowa ..
2015 KYOWA HAKKO KIRIN : Appendix to the Consolidated Financial Summary Fiscal 2015 T..
2015 KYOWA HAKKO KIRIN : Notice Concerning Change of the Number of Shares to Constitu..
2015 KYOWA HAKKO KIRIN : Consolidated Financial Summary Fiscal 2015 Third Quarter(110..
2015 Fujifilm Kyowa Kirin Biologics selects GE's innovative MabSelect SuRe LX medi..
2015 KYOWA HAKKO KIRIN : New Immunoglobulins Findings from Kyowa Hakko Kirin Co. Ltd...
2015 Valeant picks up AstraZeneca psoriasis drug after Amgen exit
2015 KYOWA HAKKO KIRIN : Submits Application for Approval in Japan for Brodalumab (KH..
2015 KYOWA HAKKO KIRIN : initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) ..
2015 KYOWA HAKKO KIRIN : Launch of Reconfigured Kyowa Hakko Kirin Global Website
2015 KYOWA HAKKO KIRIN : Revises Forecasts(39KB)
2015 KYOWA HAKKO KIRIN : Announces Results of the Phase 3 Studies of KHK4827 in Subje..
2015 KYOWA HAKKO KIRIN : Approval for ACOALAN® in Japan
2015 KYOWA HAKKO KIRIN : Cantargia licenses BioWa POTELLIGENT® Technology platform fo..
2015 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
2015 KYOWA HAKKO KIRIN : Completion of Construction for Amino Acid Manufacturing Plan..
1  2  3Next
Advertisement
Financials ( JPY)
Sales 2016 350 313 M
EBIT 2016 -
Net income 2016 19 571 M
Finance 2016 63 188 M
Yield 2016 1,71%
P/E ratio 2016 38,40
P/E ratio 2017 36,08
EV / Sales 2016 2,23x
EV / Sales 2017 2,14x
Capitalization 844 548 M
More Financials
Chart KYOWA HAKKO KIRIN CO LTD
Duration : Period :
Kyowa Hakko Kirin Co Ltd Technical Analysis Chart | 4151 | JP3256000005 | 4-Traders
Full-screen chart
Technical analysis trends KYOWA HAKKO KIRIN...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 2 104  JPY
Spread / Average Target 44%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Nobuo Hanai President & Representative Director
Yoichi Sato Director, Managing Executive Officer, GM-R&D
Kazuyoshi Tachibana Director & Managing Executive Officer
Toshifumi Mikayama Director & Managing Executive Officer
Koichiro Nishikawa Independent Outside Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
KYOWA HAKKO KIRIN CO L..-23.10%8 189
ABBVIE INC8.31%104 487
BIOGEN INC0.49%67 459
MERCK KGAA8.23%13 715
MALLINCKRODT PLC0.56%8 084
JAZZ PHARMACEUTICALS P..-10.19%7 641
More Results